Using a device to recover platelets during cardiac surgery
Official title: Study of Platelet Count Changes During the Use of Autotransfusion Device in Cardiac Surgery
Run by University Hospital, Strasbourg, France · NCT06629311 · Data updated 2026-11-12
This study tests if a special device that collects and returns your own blood during heart surgery can help keep your platelet levels up and reduce the need for blood transfusions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg, Bas-Rhin) |
| Status | Recruiting |
| Started | February 4, 2025 |
| Main results expected | September 8, 2026 |
| Study ends | September 8, 2026 |
| Registry record updated | April 3, 2025 |
| Trial ID | NCT06629311 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old undergoing standard cardiac surgery who can consent to the study.
✕Probably not a fit
Patients with anemia less than 7 g/dL, pregnant women, or those undergoing specific excluded surgical procedures will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the effectiveness of an intraoperative autotransfusion device in recovering platelets during standard cardiac surgery. The device is designed to aspirate, process, and retransfuse the patient's own blood, potentially reducing the need for external blood transfusions. The study will monitor platelet counts in adult patients who have consented to participate and have undergone the specified surgical procedures. By evaluating real-life outcomes, the study aims to provide insights into the device's performance in clinical settings.
Why it matters
Potential benefit: If successful, this study could enhance patient safety by reducing the need for blood transfusions during cardiac surgery.
How similar studies have gone: While the use of autotransfusion devices is common, this specific evaluation of platelet recovery in real-life situations is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age * Having undergone standard cardiac surgery (excluding redux surgery, dissection, endocarditis, circulatory assist and transplants) * Treated with an autotransfusion device during the surgery * Subject having expressed their consent to the study Exclusion Criteria: * Anemia less than 7 g/dL * Pregnant women * Redux surgery, dissection, endocarditis, circulatory assistance, and transplants * Contraindication to the use of an autotransfusion device * Impossibility of giving the subject informed information
Where it's running
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, Bas-Rhin, France Recruiting
Study contacts
- Study coordinator: Charles TACQUARD, PHU
- Email: charlesambroise.tacquard@chru-strasbourg.fr
- Phone: +33 6 69 55 16 08
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using blood cell ratios and procalcitonin to predict outcomes for adults with sepsis in the ICU
This project will test whether routine blood measures—neutrophil-to-lymphocyte-and-platelet ratio, procalcitonin, and total white blood cell count—can help predict outcomes for adults with sepsis in the intensive care unit.
-
Autologous Cold-Stored Platelets for Complex Cardiac Surgery
This study tests whether using a patient’s own cold-stored platelets, donated 7–10 days before surgery, improves outcomes for adults undergoing complex cardiac procedures compared with standard allogeneic platelets.
-
Analyzing blood components in patients suspected of heparin-induced thrombocytopenia
This study is testing a new way to look at blood samples from patients suspected of having heparin-induced thrombocytopenia to see if it can help doctors diagnose the condition faster and more accurately.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.